Ribitol and ribose treatments differentially affect metabolism of muscle tissue in FKRP mutant mice
Abstract Dystroglycanopathy is characterized by reduced or lack of matriglycan, a cellular receptor for laminin as well as other extracellular matrix proteins. Recent studies have delineated the glycan chain structure of the matriglycan and the pathway with key components identified. FKRP functions...
Saved in:
| Main Authors: | Marcela P. Cataldi, Qi L. Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-024-83661-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ribitol treatment rescues dystroglycanopathy mice with common L276I mutation.
by: Bo Wu, et al.
Published: (2025-01-01) -
Prospective observational study of FKRP‐related limb‐girdle muscular dystrophy R9: A GRASP consortium study
by: Lindsay N. Alfano, et al.
Published: (2025-02-01) -
Poly (ADP-Ribose) Polymerase Inhibitor Olaparib-Resistant <i>BRCA1</i>-Mutant Ovarian Cancer Cells Demonstrate Differential Sensitivity to PARP Inhibitor Rechallenge
by: Chi-Ting Shih, et al.
Published: (2024-11-01) -
Nucleotide degradation and ribose salvage in yeast
by: Yi‐Fan Xu, et al.
Published: (2013-05-01) -
Immunological efficiency of Haemophilus influenzae type b polyribosyl ribitol phosphate combined with detoxified lipooligosaccharide in a rabbit model
by: Amin Arsang, et al.
Published: (2025-02-01)